Upon dividing the samples into two groups based on the CD44 expression level (high vs. low; 13 probes), Kaplan–Meier analysis revealed significantly worsened overall survival (OS) probability in CD44-high DLBCL cases (Figure 5F and Figure S5B). The gene discussed is CD44; the disease is diffuse large B-cell lymphoma.